here - FIP

28
Jackie Parkin (Vice-President Immuno-Inflammation Therapy Area Unit, GSK, UK)
Jonathan Peck (Institute for Alternative Futures, USA)
Lloyd Sansom (Special Advisor on National Medicines Policy Framework, Australia)
Per Troein (VP Strategic Partners IMS Health, UK)
Jack Watters (Vice-President External Medical Affairs, Pfizer, USA)
Kris Weerasuriya (World Health Organization, Switzerland)
Durhane Wong-Rieger (Chair, International Alliance of Patients’ Organizations (IAPO), Canada)
Moderators:
Douwe Breimer (University of Leiden, the Netherlands)
John Chave (General Secretary, Pharmaceutical Group of the European Union (PGEU), Belgium)
Daan Crommelin (FIP/ Utrecht University, the Netherlands)
Tom Menighan (CEO, American Pharmacists Association (APhA), USA)
Ema Paulino (FIP, Portugal)
Rapporteurs to the Ministers Summit:
Harvey Fineberg (President, Institute of Medicine, USA)
Xuanhao Chan, Diane Gal, and Tana Wuliji (FIP)
FIP representatives:
Luc Besançon (FIP Acting General Secretary for Professional, Scientific and External Affairs, the Netherlands)
Michel Buchmann (FIP President, Switzerland)
Andy Gray (FIP Board of Pharmaceutical Practice Chairman, South Africa)
Henk de Jong (FIP Scientific Secretary, the Netherlands)
Prafull Sheth (FIP Vice-President, India)
Guest Contributors:
Rosemary Bryant (President, International Council of Nurses (ICN), Switzerland)
Carissa Etienne (Assistant Director General, WHO, Switzerland)
Susanne Keitel (EDQM, Council of Europe, France)
Gerben Klein Nulent (GIRP)
Otmar Kloiber (CEO, World Medical Association (WMA), France)
Bernard Mauritz (World Self Medication Industry (WSMI))
Additional Programme Advisors:
Emma Andrews (Pfizer, USA)
Andrew Bonser (Alliance Boots, UK)
Jan Smits (KNMP, the Netherlands)
Pieter Stolk (Utrecht University, the Netherlands)